Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001493152-17-009496
Filing Date
2017-08-16
Accepted
2017-08-16 14:45:28
Documents
4
Effectiveness Date
2017-08-16

Document Format Files

Seq Description Document Type Size
1 defr14a.htm DEFR14A 29476
2 image_001.jpg GRAPHIC 301447
3 image_002.jpg GRAPHIC 378204
4 image_003.jpg GRAPHIC 237810
  Complete submission text file 0001493152-17-009496.txt   1267760
Mailing Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER 1, BUILDING C, 300 INTERPACE PARKWAY PARSIPPANY NJ 07054 412-224-6100
Interpace Diagnostics Group, Inc. (Filer) CIK: 0001054102 (see all company filings)

EIN.: 222919486 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 000-24249 | Film No.: 171036055
SIC: 3841 Surgical & Medical Instruments & Apparatus